Correlation Between Lyra Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for Lyra Therapeutics and X4 Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Lyra and XFOR is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Lyra Therapeutics is 1.91 times less risky than X4 Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 50.00 in X4 Pharmaceuticals on August 28, 2024 and sell it today you would lose (16.00) from holding X4 Pharmaceuticals or give up 32.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Lyra Therapeutics |
| X4 Pharmaceuticals |
Lyra Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite Lyra Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |